home
Office of Technology Commercialization

UVM Center Demonstrates Global Health Commitment with Launch of Oral Cholera Vaccine Study

Absent for more than 100 years in the U.S., cholera continues to challenge public health officials worldwide. The infection occurs in areas with poor sanitation, poverty, and limited access to safe drinking water. Cholera causes an estimated three to five million cases and a reported 100,000 to 120,000 deaths annually, according to the World Health Organization (WHO). The University of Vermont Vaccine Testing Center aims to help combat this worldwide threat by launching a new clinical trial to test an oral cholera vaccine, and hopes Vermonters will engage in the effort to control this global disease of poverty.  Full Story

Contact UVM © 2014 The University of Vermont - Burlington, VT 05405 - (802) 656-3131